Exhibitors

GB United Kingdom
Stand No: 41C40
About Almac Group ‘Partnering to Advance Human Health' The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organisation that has organically grown for 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Location:
GB United Kingdom
Stand No: 80A11
Amano Enzyme Europe Limited is a subsidiary of Amano Enzyme Inc. that has been a major producer of enzymes in Japan for nearly 70 years. We are located in the United Kingdom and supply customers across Europe with Amano's speciality enzymes for biocatalysis, digestive aids, anti-inflammatory, diagnostics, food processing and other industrial use. In addition, we are launching sterile enzymes applicable to cell/tissue dissociation in tissue reengineering such as breast reconstruction as well as to infertility treatment. Enzymes are environmentally-friendly alternatives and Amano Enzyme is committed to contributing to the environment and the society through our enzymes.
Location:
Sub-event: CPHI
Zone: API
US United States
Stand No: 41B65
Amarantine Pharmaceutical is a successful pharmaceutical company which deals with the generics, new drugs, and healthcare products. We have a rich product portfolio of 300 products which offers the transformative treatments and life changing impacts for the patients. Our product portfolio covers the Intermediates, APIs and FDF for the technology transfer and commercialization. Currently, We are mainly focusing on out- licensing especially Oncology, UDCA, MDI and DPI. Also, we are interesting to Licensing in Innovative drugs for China market.
Location:
AR Argentina
Stand No: 101C60
AMEGA Biotech is focused on biosimilar products development and manufacturing, from cell line engineering and drug substance to drug product. Our global presence includes Turkey, MENA region and over 20 countries. AMEGA Biotech builds and fosters worldwide solid strategic alliances and partnerships for co-development, technology transfer, distribution and clinical trials.
Location:
IN India
Stand No: 40D68
New
A small group of Rubber Technologists, Management Graduates and Chartered Accountants came together and gave birth to Ami Polymer Pvt Ltd. The company started operations in 1996 to manufacture the distinguished, technically innovative and challenging import substitute Silicone and Viton Rubber Products for most precious and intricate applications mainly for the for Food, Pharma, Medical and Heavy Engineering, Thermal Power Stations and PSUs. Today, the company holds a strong customer base and enjoys a high reputation among the major pharmaceutical giants in India and our products are exported to the overseas customers as well.
Location:
Sub-event: PMEC
Zone: PMEC
US United States
Stand No: 90C90
Amneal Pharmaceuticals LLC, a privately-held company with US headquarters in New Jersey and international headquarters in Switzerland, is one of the largest and the fastest growing generics pharmaceutical manufacturers in the United States. Founded in 2002, Amneal now has more than 5,000 employees in North America, Asia, Australia and Europe, working together to bring high quality affordable medicines to patients worldwide. Amneal has significantly expanded its portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas.
Location:
US United States
Stand No: 80G22
Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more twenty-five years. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Solutions (DDS), Active Pharmaceutical Ingredients (API), and Drug Product Manufacturing (DPM). Our DDS segment provides comprehensive services from hit identification to IND, including expertise with diverse chemistry, library design and synthesis, in vitro biology and pharmacology, drug metabolism and pharmacokinetics, as well as natural products. API supports the chemical development and cGMP manufacture of complex API, including potent, controlled substances, biologics, peptides, steroids, hormones, cytotoxic compounds and sterile API. DPM supports development through commercial scale production of complex liquid-filled and lyophilized parenterals, sterile suspensions and ophthalmic formulations.
Location:
Sub-event: CPHI
Zone: API
FR France
Stand No: 101C66
Dedicated to What Matters ANGUS Life Sciences, the world's only fully integrated manufacturer of TRIS AMINO buffers, provides high-quality production chemicals for biotechnology and pharmaceutical applications. With complete raw material traceability, reliable global supply, specialized testing, and custom packaging solutions, our dedication to providing the best products for your pharmaceutical and biotechnology R&D, scale up and production is more than just an ongoing commitment. It's what we do.
Location:
GB United Kingdom
Stand No: 111D42
Apollo Scientific offers a huge range of organic intermediates (currently over 75,000). In our own UK laboratories we manufacture fluorochemicals and key heterocyclic building blocks in quantities from just a few grams to over 50kg. Many of these compounds are novel and we are regularly supplying interesting new molecules to the pharmaceutical industry from an initial small requirement, through kilo-lab and beyond. Apollo also undertakes custom synthesis work, and has agreements in place with approved third-party toll converters. Therefore if required, quantities over 100Kg of our own manufactured intermediates can be provided using technology transfer of Apollo's procedures.
Location:
NL Netherlands
Stand No: 41N14
New
Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development' as not just offering a technical solution but always part of a broader product-oriented strategy.
Location:
DE Germany
Stand No: 101C76
AXXO is a leading international supplier with a rich product portfolio covering a wide range of therapeutic categories including active pharmaceutical ingredients (API), intermediates, finished dosage forms as well as the latest development in the field of biotech production i. e. monoclonal antibodies (MAB). Our international operating company would be pleased to offer you our custom-made services from developing, manufacturing and marketing APIs, finished dosage forms or registration dossiers to full health concepts like machinery & equipment for your own manufacturing. We are present in the EU, in a huge number of the CIS countries and in various South American and Middle East markets. Our product portfolio embraces APIs as well as finished formulations. Our dynamic and highly-motivated team is investigating, developing, producing and distributing innovative pharmaceutical products. We are offering just-in-time delivery, customized product parameters as well as registration assistance. Our expertise consists in the development and registration of...
Location:
Beijing Global Biologicals Co Ltd (GBC) is a biotechnology-driven company specialized in R&D and manufacturing of pharmaceutical ingredients and has two big manufacturing bases in Shandong of China. GBC provides the professional integration services of technology transfer, strain improvement, process optimization, research(CRO) and contract manufacturing (CMO) for APIs, intermediates, nutraceuticals, enzymes and agrochemicals. Our products include: Virginamycin,Avilamycin,Nicergoline,Astaxanthin,Glutathione (GSH), Mupirocin, Fusidic acid, UDCA,Milbemycin, Pneumocandin B0, Acarbose, G418 sulphate, Ergothioneine, Pyrroloquinoline quinone (PQQ),etc . Our Strains and Biotechnologies include:- strain improvement, biofermentation, biotransformation, enzymatic, DSP and purification, semi-chemical synthesis, scale-up, technology transfer,engineering consulting. Welcome to visit us web:http://en.globalbiologicals.com/
Location:
Sub-event: CPHI
Pavilion: China Pavilion
RU Russia
Stand No: 62B31
BIOCAD is fully integrated pharmaceutical company, excels at full-cycle drug discovery and development, large-scale manufacturing of therapeutics for the treatment cancer and autoimmune disorders. Having a number of mAb biosimilars on the market, BIOCAD has become a top manufacture of high value chemical APIs – glatiramer acetate, pemetrexed and others.
Location:
Sub-event: CPHI
IN India
Stand No: 80J80
Established in 1978, Biocon Limited, is India's largest, and Asia's leading, biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide. We develop, manufacture and deliver a rich portfolio of Small Molecules APIs & Formulations and Complex Biologics - both Novels and Biosimilars - including MAbs, rh-insulin& Insulin Analogs. Biocon's robust product portfolio includes the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG and India's first biologic BioMAb-EGFR; for head and neck cancer. It has now successfully developed its second novel biologic Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, being introduced as Alzumab; for psoriasis in India, in 2013.
Location:
Sub-event: CPHI
Zone: API
FI Finland
Stand No: 90F68SSP
Our patented, safe and unique Acetium products, patient-friendly GastoPanel blood test and BIOHIT quick tests provide a purpose-built range for gastrointestinal diagnosis and stomach health. Our core competence is based on early diagnosis and prevention of gastrointestinal diseases binding carcinogenic acetaldehyde from stomach and saliva innovative Point-of-Care quick tests aimed to gastroenterologists Our clinical trials are aiming at prevention of migraine type headache treatment of atrophic gastritis indications and smoking cessation
Location:
IN India
Stand No: 91B80
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
Location:
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products. Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media. For updated list of products, send an email to info@biophore.com
Location:
Sub-event: CPHI
Zone: API
AR Argentina
Stand No: 101A66
Biosidus, is an Argentina-based company pioneer in biotechnology, which for three decades have been developing and producing top quality recombinant proteins. Since the launch of epoetin in 1990, Biosidus has increased its presence worldwide across Latin America, Eastern Europe, Africa, Middle East and Asia. Today, we are selling our products in more 45 countries worldwide. This also includes our own presence in strategic markets through JVs. Biosidus's portfolio consists of eight key recombinant human proteins across the therapeutic divisions of Nephrology, Hematology, Multiple Sclerosis, Endocrinology, Oncology and Hepatitis: epoetin, filgrastim, lenograstim, interferon beta 1a, somatropin, teriparatide, interferon alfa 2a and interferon alfa 2b. Together with this, we have the following products in different stages of development: peginterferon alfa 2a, pegfilgrastim, interferon beta 1a (30 mcg intramuscular), interferon beta 1b and agalsidase. Recently, we have enlarged our portfolio by including generic products (small molecules) to our Onco-Hematology, Oncology and Immunosuppressive areas...
Location:
US United States
Stand No: 80F92
New
BioSpectra – Booth 80F92: Your Premier Partner for US-Manufactured Life-Science Chemicals, Regulatory Compliance & Product Development – Your “Bespoke” Life Science Partner: BioSpectra is the premier US-Manufacturer of Life Science Actives, Intermediates, Excipients, Biological Buffers and Custom Products. FDA registered and inspected, we operate under true, US-GMP, IPEC and ICHQ-7 requirements out of 175,000 square feet of state-of-the-art facilities only 2-hours from NYC in historic Pennsylvania. BioSpectra stands apart as the only manufacturer of these products in the USA operating under these rigorous quality standards. Our comprehensive Total-Quality-System and Regulatory Support Services exceeds any other competitor, anywhere in the world, for the products we provide. Core Products: · Actives: KBr, KCl, NaCl, Tromethamine, Urea, & Custom APIs/ Oral, Transdermal & FUISA (For Use In Sterile Applications). · Excipients & Intermediates: Tromethamine, Guanidine HCl & Thiocyanate, HEPES, L-Cystine HCl, MOPS, Sugars (Galactose, Sucrose, Trehalose), TRIS HCl, Uracil, Urea, Ammonium Sulfate ·...
Location:
Sub-event: CPHI
Zone: API
CH Switzerland
Stand No: 110F30
Biosynth is a manufacturer and distributor of organic fine chemicals in the field of enzyme substrates, indole derivatives and speciality chemicals for microbiology, molecular biology, diagnostics, pharmaceutical industry, chemical industry, food and environmental testing.
Location:
IT Italy
Stand No: 91F10NEP
New
Biotrading is a 45-years experience company strongly oriented to the field of dietary and food supplements and nutritional pharmaceutical manufacturing products within neonatology and pediatric. Since 2010 Biotrading has been working too in the field of geriatrics, gastroenterology and oncology, and since 2015 also in sports and veterinary, by investing in R&D, innovation and high quality. Production processes are certified and special attention is paid to the search for optimal solutions of safety, intake and practicality of the products. Biotrading bases its production strategy on dynamism, technical and scientific innovation and on the quality of its products . Micellar solution, a special pharmaceutical technology, is our strength point and it makes the difference of our innovative products. Our mission is aimed to improve the well-being of the individual by offering and developing high quality and innovative food supplements. A specific sector study that analyzed the last four financial statements deposited...
Location:
BR Brazil
Stand No: 61C40
Blanver is a Brazilian multinational company with more than 30 years of experience, 3 plants in Brazil and offices in the U.S. and Spain, which develops, manufactures and markets Finished Dosage Forms (FDFs) and pharmaceutical raw materials. Our pharmaceutical business plan is to export our FDF portfolio in the HIV and HCV segment, from Brazil through strategic and meaningful partnerships. We are seeking strategic alliances with international partners of recognized quality to license and commercialize innovative and established products in segments such as Oncology and Hematology throughout Brazil and Latin America. Become our partner, contact us for more information. +55 11 4138-8200 | contatobr@blanver.com.br
Location:
Sub-event: CPHI
BR Brazil
Stand No: 90D62
Blau Farmacêutica is a Brazilian pharmaceutical company, leader in Latin America, present in Argentina, Chile, Colombia, Peru and Uruguay. The company is a pioneer in highly complex medicines, specialized in biotechnology, oncology, nephrology, hematology, infectious diseases and others. Celebrating 30 years, Blau Farmacêutica is pleased to show your strength, competence and technique experienced in developing more than 100 different products. Blau's portfolio includes products, which are available for a wide range of applications. The excellence of these products, are a proof of the company's devotion to customer satisfaction and the well-being of its consumers.
Location:
US United States
Stand No: 91H52NEP
New
Boston Biopharma is a US-based pharmaceutical company that specializes in providing the highest quality specialty medications worldwide, in particular to emerging countries. We do this through pioneering R&D, and licensing, manufacturing, and commercializing the finest therapeutics especially oncology, multiple sclerosis, and immunology. Our EMEA operations office is located in Malta and we have a significant market presence in Algeria, Iraq, and the GCC. With a focus on product quality and operational flexibility, our firm brings decades of healthcare industry expertise to some of the most difficult markets.
Location:
DE Germany
Stand No: 111C81
As one of the leading German manufacturer of ethanol for the pharmaceutical industry, the commitment of BrüggemannAlcohol Heilbronn GmbH is constant, pharmaceutical purity. The company is part of the BrüggemannGroup and is based in Heilbronn since 1868, where ethanol is produced and distributed. Due to the second production site in Wittenberg BrüggemannAlcohol Heilbronn GmbH is able to uphold constant, fast and flexible delivery. In pharmaceutical applications ethanol is used in its purest form in medications, homeopathic products, disinfectants, as well as for extractions of plant-based active substances – from excipient to active pharmaceutical ingredient BrüggemannAlcohol Heilbronn GmbH can offer a wide product portfolio. In order to reach the highest requirements, BrüggemannAlcohol produce ethanol in pharmaceutical qualityaccording to current pharmacopoeia (Ph. Eu.) as well as GMP-quality. Since 2016 the company is certified producer for GMP-ethanol, and offers ethanol in 96% or 100%, undenatured or denatured quality. Packaging is available from 5l...
Location:
Sub-event: CPHI
Zone: API
IT Italy
Stand No: 41A23
New
Capua BioServices is a global provider of high-quality services in the field of custom microbial process development and manufacturing. We offer dedicated solutions for proteins, (high-value) small molecules and microorganisms for applications in pharma, food, feed and bio-industrial markets. We are the largest, independent, beta-lactam free microbial contract manufacturing facility in Europe. Our facility is located near Naples, in the south of Italy and has a total fermentation capacity of about 1400 m3 which is spread over two separate fermentation areas. Our associated downstream processing capabilities are spread between multiple, isolated recovery and purification plants with a large diversity of unit operations capable of handling multiple projects in parallel. Recently, we have significantly expanded our spray-drying capabilities, up to pharma API grade. For more than 50 years, we have built a track record based on our extensive experience in working with a variety of bacterial, yeast and fungal systems. We...
Location:
Sub-event: ICSE
Zone: NEP ICSE
FR France
Stand No: 111G32
CEPiA (Commercial & External Partnership, Industrial Affairs) is an organization within the Industrial Affairs of Sanofi fully dedicated to third parties. We offer API Contract Manufacturing & Custom Synthesis competences from small molecules to biologics, from lab scale to commercial quantities. Additionally, we offer our extensive drug product facilities.
Location:
DE Germany
Stand No: 102G21
CG Pharma & Nutrition is a globally active GMP-manufacturer and GDP-distributor of pharmaceutical starting materials, Excipients and API. We are holder of a Drug Manufacturing Authorization according to German Medicinal Products Act. Our product portfolio covers more than 650 raw materials for the pharmaceutical industry. We are able to formulate and produce solid and liquid dosage forms under clean-room conditions (C&D). Mixing tanks, milling plants, sieve systems and silos are available for additional processing and re-packing steps. We manufacture aqueous solutions of starting materials, Purified Water (AP) and Water for Injection (WFI) according to EP/USP.
Location:
Sub-event: CPHI
Zone: Excipients
CN China
Stand No: 110D32
LonGo Chem is a professional and reputable company in trading and exporting chemical intermediates, including Pharmaceuticals, Pesticides, Dyes, Flavors, Plant Extracts etc. Around the world, we have established long-term business relationships with many reputed international chemical companies. In domestic market, we have built tight cooperation relationship with manufacturers, and high-tech industries.
Location:
CN China
Stand No: 80R41
Changzhou Welton Chemical Co Ltd located in Changzhou Binjiang Chemical Zone, Jiangsu Province, China, is specialized in providing high quality biological buffers, pharmaceutical intermediates, and the services of customer synthesis for fine chemicals intermediates. Our former plant named Changzhou Xinghui Chemical Co Ltd was found in 1997, which stands in Changzhou High Technology Developing Area, is very convenient for the shipment of goods. We are now the leading supplier and manufacturer of biological buffers in China and has built up an extensive customer base abroad.
Location:
Sub-event: CPHI
Zone: API
Pavilion: China Pavilion
GB United Kingdom
Stand No: 40G42
ChargePoint Technology are market leaders in powder containment and aseptic transfer valves providing operator safety and sterility assurance for the pharmaceutical, biotech, chemical and other process industries.
Location:
Sub-event: PMEC
Zone: PMEC
DE Germany
Stand No: 110D12
ChemCon is a world leader for contract research and custom manufacturing of small molecule APIs and fine chemicals in the areas of organic, inorganic and polymer chemistry. We specialize in synthetic route development and small scale manufacturing (from grams up to hundreds of kilograms). Our products are used worldwide for pre-clinical development, during clinical trials and as drug substances. Our facilities include state-of-the-art research laboratories, FDA inspected clean rooms and all necessary chemical and microbiological analytical suites required for API release. ChemCon - your expert partner for project transfer to cGMP compliant manufacturing, cGMP documentation and drug master file creation.
Location:
CN China
Stand No: 110G57
ChemFuture PharmaTech (Jiangsu) Ltd is a newly founded chemistry outsourcing company by Dr. Wayne W. Lai and Nanjing Honghe Investment Ltd. Dr. Lai obtained his Ph.D. Degree in Organic Chemistry in 1992 from State University of New York and performed his ostdoctoral research at Harvard University. Since then he has been working in biotechnology and pharmaceutical industries including a custom synthesis company for 7 years and a major multi-national pharmaceutical company for 4 years. Furthermore, our technological management team consists of other experienced Ph.D and MS returnees who are familiar with the industry. Located in Wuxi New District, 2 hour driving from Shanghai, China, ChemFuture is dedicated to provide the global pharmaceutical and biotechnology industries with professional chemistry services and novel synthetic building blocks and intermediates. Our R&D building is equipped with Bruker 400MH NMR, Agilent 1200 HPLC, Analytical LCMS, Preparative LCMS, GCMS, Microwave synthesizers and other modern equipment. In...
Location:
KR South Korea
Stand No: 90G67
Chemport Inc. was established in 2001 and has been a leading Omega-3 fatty acid manfuacturer with our own high technology. We are capable of producing up to 97% of EPA, 95% of DHA, and 95% of EPA & DHA blends omega-3 fish oil. We are one of the extremly few capable companines in the world which can supply two FDA approved prescribed fish oil drus, Omega-3 Acid Ethyl Esters called Lovaza and Omacor and EPA min. 96% called Vascepa along with high concentrated fish oil supplements.
Location:
CN China
Stand No: 110A24
New
Chengdu Aslee Biopharmaceuticals Inc is specialized in conducting research, production and sale of biopharmaceuticals, and highly-valued fine chemicals, and devoted to the research and development, custom synthesis and process as well as technical consultancy in pharmaceuticals, drug intermediates and organic-electric materials.
Location:
Sub-event: CPHI
Zone: API
CN China
Stand No: 110A56
Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004. With 50 key technologies for large-scale production of domestic and foreign peptide drugs, we are a leading manufacturer of peptides by solid-phase chemistry. In addition, our team has the ability to perform product development, technology transfer, technical services and large-scale multi-kilogram single batch production capacities. As an industry leader in the domestic solid-phase peptide market, we have recently received approval as a registered US FDA manufacturing facility with zero 483 citations.
Location:
Sub-event: CPHI
Zone: API
Pavilion: China Pavilion
Categories:
CN China
Stand No: 110A24
New
Chengdu Yazhong Bio-pharma was founded in 2002, whose main products are Diosmin, Resveratrol, Ergosterol. We have over 10-year experience on Diosmin, which is granted GMP and WC. For Diosmin series, we have Diosmin EP 90%-102%, Diosmin/Hespridin, Diosmin Micronized. GMP, MSDS, WC and DMF are available.
Location:
Sub-event: CPHI
Zone: API
Chongqing Quanxinxiangsheng Bio-pharmaceutical Co Ltd, established in 1995, is a manufacturer of bio-pharmaceuticals (enzymes). The company has enjoyed a good reputation in the Chinese market for about two decades and it is now it the biggest supplier of Pepsin and pancreatin in China. The company covers an area of nearly 40 Mu, buildings nearly 8000 squaremeters, the green area of the factory is more than 40%, a beautiful environment. The company is mainly specialized in developing and manufacturing API enzymes) extracted from animal organs, has been authorized with the GMP certificate issued by the State Food and Drug Administration and built a strict quality control system covering purchase of raw materials, production processing, sales andafter-sales service .
Location:
Sub-event: CPHI
Zone: API
Pavilion: China Pavilion
Categories:
ES Spain
Stand No: 90C91
Cinfa Biotech is headquartered in Pamplona, Spain, with offices in Munich, Germany. The Company develops, manufactures and commercialises high-quality biosimilars for oncology and inflammatory diseases to address the growing need for affordable therapies. An expert team specialised in biosimilars is conducting product development, clinical studies, manufacturing and quality control in Europe, according to the highest quality standards. Cinfa Biotech's lead product candidate is B12019, a biosimilar version of Neulasta® (pegfilgrastim) used to treat chemotherapy-induced neutropenia. The Marketing Authorisation Application for B12019 for the European Union was accepted for review by the EMA in September 2017. The clinical program was based on scientific advice from EMA and included two studies, which confirmed the analytical and biofunctional similarity of B12019 and Neulasta® in highly sensitive clinical study settings. Comparative analytical and functional data are currently being generated for B12019 regarding EU-authorised and US-licensed reference product. A briefing package for FDA will be...
Location:
GB United Kingdom
Stand No: 61D32
Established in 2011, CMAC is a world-class international centre for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future. The approaches developed and adopted within CMAC have been established through close collaboration with industry and the support of its partners, which include GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Roche, Lilly and Takeda. The CMAC National Facility offers contract research support to industries through the delivery of services within crystallisation (batch & continuous), process development, formulation, product/process analysis and advanced materials characterisation. We are working with a range of companies based within the chemicals, agrichemicals and food industries applying our expertise in crystallisation, PAT and high end analytical services to these fields.
Location:
Sub-event: CPHI
GB United Kingdom
Stand No: 41M02
Contract Manufacturing Excellence with Cobra Biologics Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing a comprehensive biologics and pharmaceuticals service offering. Our multi-functional and experienced project teams nurture customers' products through to clinical and commercial manufacture within three GMP approved facilities. Expertise Cobra is a contract development and manufacturing organisation (CDMO) supporting the global life sciences industry in the development and manufacture of monoclonal antibodies (mAb), recombinant proteins, DNA, viruses, phage and cell line derived products and pharmaceuticals for clinical trials and commercial supply. For Gene Therapy products we can produce DNA, Adenovirus, AAV, Lentivirus and other virus material for both clinical and commercial supply. Cobra provides manufacturing technologies, platforms and solutions for gene therapy products. For our AAV and Lentivirus customers we have developed a High Quality DNA platform process to enable the rapid supply of small quantities of DNA material for the production...
Location:
US United States
Stand No: 111F53
Codexis is a leading protein engineering company applying innovative technologies to Unlock the Power of ProteinsTM. We work collaboratively with our clients to advance protein optimization and production, enabling breakthrough developments in pharmaceuticals and fine chemicals, biotherapeutics, food & beverage, agriculture and other industries.
Location:
Sub-event: CPHI
Zone: API
IT Italy
Stand No: 42B12
CTP SYSTEM Srl, founded in 1990, is leader in Italy and one of the most important companies in Europe for the PHARMACEUTICAL, CHEMICAL, HEALTHCARE, COSMETICS, FOOD, and VETERINARY FIELD. In 2017, CTP SYSTEM enters AKKA TECHNOLOGIES Group, already a leader in the development of technology services for the Automotive, Railway, Aeronautics, Space & Defense, Oil & Gas sectors. The integration of CTP SYSTEM within the AKKA Group allows enhancing in synergy each other's competence, also creating a specialized network for the Life Sciences world. CTP SYSTEM provides management and delivers consulting services to support the customers in each step of the product life cycle, from Research & Development to Process & Plant Engineering, Technology Transfer, Regulatory Support, Process & Plant Qualification, enabling IT Solutions. More than 160 high-specialized consultants and the dedicated employee's team of CTP SYSTEM, in addition to over 350 experts of AKKA Group, create a winning NETWORK...
Location:
UA Ukraine
Stand No: 91F46
PrJSC “Pharmaceutical Firm “Darnitsa” is one of the largest local manufacturers of medical products in Ukraine. It has capacities that allow producing more than 460 million of ampoules, 4.2 billion of tablets, 15 million of LVP solutions based on BFS technology, 31 million of sterile vials of antibiotics and more than 49 million of tubes of soft medicinal forms, including annual production capacity of the site drops of 40 million of vials per year. “Darnitsa” has extensive experience in development of value-added generics, efficient manufacturing processes and operations. Darnitsa possess a broad product portfolio and open to in/out-licensing, contractual manufacturing of different forms including LVP solutions.
Location:
CH Switzerland
Stand No: 80G85
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. More information can be found at www.dsm.com.
Location:
Sub-event: CPHI
Zone: API
EBInnov® research laboratory is organized around four areas of expertise:- 1. Innovation- Creation of active ingredients or excipient. 2. Production- Optimization of the production of natural or synthetic substances. 3. Formulation-Design and validation of methods for the formulation and sensory evaluation of pharmaceutical products. 4. Prevention- Evaluation of industrial and environmental risks, product protection The EBInnov® lab includes all the scientific activities of the faculty and students of the EBI. From research to entrepreneurship, teachers carry out work connected to the problems of our application areas. EBInnov has facilities dedicated to each of its R & D activities organized in technological platforms and laboratories. Each facility is equipped with all the hardware for performing the techniques necessary for research and applications. They can be used for pedagogical manipulations, but also to development projects or research, or be used by the incubated companies or companies with a need for technology transfer.
Location:
DK Denmark
Stand No: 91H71
The Cannabinoid CBD (Cannabidiol) has been shown to act as a 5-HT1A receptor agonist, an action which is involved in its antidepressant, anxiolytic and neuroprotective effects. Endoca developed technology to produce up to 99% pure cannabinoids from Hemp. We developed industrial scale process for 99% pure CBD, CBDA, CBG, CBGA.
Location:
BE Belgium
Stand No: 111C04
New
Enzybel is the reference for natural enzymes solutions. We develop Plant & Animal-derived enzymes and provide innovative solutions for the industry. Our enzymes are produced for Food & Beverages, Feed & Petfood, Pharma/Nutraceuticals & Technical, with a unique focus: high quality products with full traceability at competitive prices.
Location:
Sub-event: CPHI
Zone: API
GB United Kingdom
Stand No: 61D32
EPP is a GLP compliant Contract Research Organisation (CRO) assisting pharmaceutical companies with pre-clinical environmental sciences testing. We ensure the smooth and efficient registration of your products by following OECD guidelines and can provide bespoke testing as required. We specialise in GLP complaint testing in the areas of: · Ecotoxicology; aquatic, marine and terrestrial · Environmental fate · Fish metabolism studies · Controlled substances · Storage stability · Physico-chemical testing · NMR EPP can additionally support your pharmaceutical registration and QC testing processes by providing custom synthesis of rare or unusual (non-commercially available) analytical reference standards of metabolites, impurities or degradants which are comprehensively certified to GLP compliant standards including by the use of GLP compliant NMR (both qualitative and quantitative).
Location:
Sub-event: CPHI
RS Serbia
Stand No: 41A47
New
ESENSA is a company that produces dietary supplements, medical devices and general use products Including cosmetics and biocides.. It was founded in 2002 as a production department within FARMALOGIST, and as of 2007 has been operating under the name of ESENSA d.o.o. and is 100% privately owned. In 2009 ESENSA d.o.o obtained the permit to manufacture medical devices. In 2011 it acquired a permit to distribute pharmaceuticals, medicine and raw materials, as well as the permit to produce magisterial and galenic formulas in original packaging. Our vision, mission and strategy are defined by assuring the quality of our product as well as good management. We see this as the true formula for attaining our goals as a company. Esensa has certified quality management systems according to the requirements of ISO 9001:2008 with the certification body SGS, for the development and production of dietary supplements, medical devices and general purpose devices...
Location:
Sub-event: ICSE
European Medical Contract Manufacturing B.V. (EMCM) is a centre of excellence in developing and manufacturing sterile medical products for Medical Device and Pharmaceutical companies. At our GMP and ISO accredited and US-FDA and Anvisa inspected facilities, we focus on the (contract) manufacturing of organic solvents, aqueous solutions, powders, and highly viscous suspensions and gels. We pride ourselves on our flexibility, being able to produce small or large scale batches customised to our customers' needs. The products we currently manufacture can be classified under Pharmaceuticals, Medical Devices and Tissues Grafts. Be it ampoules, vials, syringes, pouches, bottles or blisters, we support opportunities that enable our customers to bring their innovations to the market.
Location:
IN India
Stand No: 80F02
Since 1991, Exim started to promote Indian origin Pharmaceutical products and has built a solid reputation as a reliable, transparent and ethical partner. With exceptional sourcing abilities and strong regulatory, logistics backup, we successfully service customers spanning 50 countries. Our strength are API's, Intermediates, Excipients, Custom-Synthesis , Nutraceuticals & Vitamins.
Location:
Sub-event: CPHI
Zone: API
CN China
Stand No: 60A01
Frontier Biotechnologies Inc. is a research-based pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing significant unmet medical needs. - Its lead product candidate ALBUVIRTIDE, a novel long-acting anti-HIV agent. - The second lead drug candidate AB001 is a third generation topical patch for the management of pain and inflammation, and a phase 2 clinical trial of AB001 for the treatment of chronic low back pain was successfully completed in the US. - Frontier Biotechnologies, Inc., announced it has signed an agreement with The Rockefeller University of the US for the worldwide license for combining 3BNC117, a novel broad-spectrum HIV neutralizing antibody, with ALBUVIRTIDE for the treatment and prophylaxis of HIV infection and AIDS.
Location:
Sub-event: CPHI
GB United Kingdom
Stand No: 60D60
FUJIFILM Diosynth Biotechnologies is a Global Contract Development and Biomanufacturing Organisation, offering services in process development, analytics and cGMP production for recombinant proteins and viral products, from first in man to commercial. With 1200 staff, including 250 process scientists, and cGMP up to 5000L, we have the capability to support the full drug life cycle.
Location:
Sub-event: CPHI
BE Belgium
Stand No: 40F10
It's a truly dynamic time for the global pharma industry, and CPhI Worldwide & P-MEC India provides an opportunity to meet the GEA team, discover the latest trends, technologies and insights and, above all else, drive new partnerships, do business and grow. By investing in and supporting these events, we're highlighting our ongoing support for the current and future pharmaceutical industry. Learn all about GEA's solutions for the Solid-Pharma, Liquid-Pharma and Bio-Pharma industries. Get ‘hands on' with our equipment for batch and continuous productions and take part in "live" demonstrations and meet all our experts from every sector of the pharmaceutical market in one place.
Location:
Sub-event: PMEC
Zone: PMEC
CN China
Stand No: 80C83SSP
GL Biochem, founded in 1998, is specializing in peptide reagent, generic peptide, custom peptide synthesis, custom antibody and providing various peptide products and services for Pharmaceutical company, biotechnology company, University and institute. GL Biochem can provide all kinds of peptide products including cGMP peptide, peptide reagent from mg to kg and our products are now well known in more than 50 countries. We have offices in major cities around the globe. We presently employ over 1000 staffs. GL Biochem has 35,000 sqm. of production site, 5,000 sqm. of R&D center and 500 sqm. of cGMP workshop. Over 50% staff are directly involved in peptide synthesis. We continuously improve production capability, and at the same time emphasize on technology advancement. GL Biochem is the global leader in Peptide Products and Cutsom Peptide Synthesis.
Location:
Sub-event: CPHI
Zone: API
CN China
Stand No: 101D40
Guangzhou Bairui Medicine Co Ltd focuses on R&D, manufacturing and sales of plant-extracts, medicinal intermediates and raw materials. We provide quinine dihydrochloride, acrichin dihydrochloride, hydrocortisone sodium succinate, scopolamine butylbromide, chloramphenicol sodium succinate, ethambutol dihydrochloride, flucloxacillin sodium, chloramphenicol hemisuccinate, orphenadrine citrate, quinine hydrochloride dihydrate, quinidine sulfate dihydrate, cloxacillin sodium, dicloxacillin sodium, atenolol, paclitaxel, cefaclor, cefixime, benflumetol and benazepril hydrochloride. API & Finished Dosage *A distributor of imported Intermediates, APIs and finished dosage * IDL registration of API and Formulation * Formulation development for domestic companies * ANDA Filing in US Plant Extracts Refine Chemicals Factories: scale-up & custom synthesis (Anhui Bairui) plant extracts (Hubei Enhua)
Location:
Sub-event: CPHI
Zone: API
Pavilion: China Pavilion
GB United Kingdom
Stand No: 92H79
Harmonium Pharma is a multinational company based in London, focused only on diabetes, which provides products and solutions for the daily management of this disease.Differently from other players focused on the management of hyperglycemia and on medical instruments (insulin, hypoglycemic, glucometers, strips, needles, insulin pumps), Harmonium Pharma provides a range of products which help day-by-day people with diabetes to manage aspects such as hypoglycemia, lipodystrophy, foot care, fingertips care, need of low glycemic index foods and prevention of complications such as neuropathy and retinopathy.
Location:
FR France
Stand No: 41D50
Holochem is a Contract Research Organization offering R&D services for the development of key intermediates and APIs. We produce pre-clinical batches from milligram to kilo-scale for early-phase formulation and toxicological use. Our custom synthesis services cover all phases of Chemical and Process development, from the design of an original synthesis pathway and the development of the industrial process, to the development and validation of the associated analytical methods. We have expertise in various advanced chemistry technologies and compounds including small and complex molecules, Highly Potent APIs, ADC linkers, impurities and metabolites. All key intermediates, active ingredients and reference substances developed by Holochem are fully EP/USP/ICH compliant and benefit from IMPD/IND/DMP regulatory support. As part of our integrated services we can assist our pharmaceutical customers with the drafting of their regulatory files. At Holochem we value close collaboration with our customers and open communication at all stages of the development process...
Location:
Sub-event: ICSE
Pavilion: France Pavilion
FR France
Stand No: 41D50
Holodiag is a Contract Research Organization offering R&D services dedicated to pharmaceutical solid state and crystallization process. ¤ Analytical characterizations : XRPD, DSC/TGA, DVS, polarimetry, FTIR/UV, pKa/logP/logD, KF, IDR. ¤ Solid state investigations : screenings (polymorphs, salts, co-crystals, amorphous), stability/solubility/dissolution. ¤ Crystallization process : development/optimization, product recovery, isomer separation, filtration.
Location:
DE Germany
Stand No: 40K40
THE HOSOKAWA MICRON GROUP The Companies of the Hosokawa Micron Group offer a comprehensive range of services on the sector of technology, machine design and system engineering in accordance with all national and international pharmaceutical quality standards and have become a market and technological leader when it comes to mixing, blending, drying, grinding, micronising, jet milling, classifying, compacting, agglomerating, filling and weighing of powders and particles used to make tablets, capsules, granules, infusions and injection solutions as well as high-tech solutions for sterile processing systems. HOSOKAWA ALPINE Aktiengesellschaft, Augsburg, Germany Formed in 1898, Hosokawa Alpine's range includes the development, design and manufacture of components and turnkey systems to produce powders, granules and bulk materials for the chemical, pharmaceutical, food, minerals, metals and recycling industries. The name ALPINE stands for competence in all areas of comminution technology. The long years of close cooperation between our engineers and the development departments of...
Location:
Sub-event: PMEC
Zone: PMEC
DE Germany
Stand No: 40D31
With its core competences in its business areas laboratory services, reference standards as well as vigilance and quality services, HWI pharma services GmbH offers are wide range of services for the pharmaceutical industry. We have more than 25 years of experience in analytical method development and validation, trace analysis, troubleshooting, quality control and stability testing of APIs, excipients, and medicinal products as well as substance-based medical devices and medical devices. We have a certificate of GMP compliance and a manufacturing authorisation for the release testing of clinical and commercial batches. Our reference standard concept ranges from a wide selection of qualified primary reference standards and working standards to the complete just-in-time supply to quality control laboratories. We have our own GVP-compliant pharmacovigilance system and offer comprehensive support concerning the safety of medicinal products and medical devices. Along with the product development of HWI development GmbH and the regulatory services of...
Location:
TR Turkey
Stand No: 90G75
ILKO is a subsidiary of Selcuklu Holding which has strong institutions across various economic sectors. ILKO was founded by pharmacist Mustafa Öncel who was active in the pharmaceutical industry since 1973, resulting with successful sale of the previous pharma company to international partnerships, in 2006. Öncel family has invested again in pharmaceutical industry with about their 50 years of experience by young company, ILKO. ILKO has started its business activities in 2012. As of 2017, ILKO has over 600 employees with its own licensed 47 products within 185 different forms in different therapeutic areas like; Central Nervous system, Respiratory System, Alimentary and Metabolism, Anti-infectives, Musco-Skeletal System, Cardiovascular System and Heamatology. ILKO's production facilities have been approved for EU-GMP certificate by MHRA–UK and through its wide portfolio ILKO has business to international markets in several countries. The production facility of the company is the largest pharmaceutical manufacturing investment in Anatolia. The...
Location:

Pages